» Articles » PMID: 34659602

Post COVID-19 Vaccination Neuromyelitis Optica Spectrum Disorder: Case Report & MRI Findings

Overview
Journal Radiol Case Rep
Publisher Elsevier
Specialty Radiology
Date 2021 Oct 18
PMID 34659602
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

There are rising concerns among the medical community and the public regarding the side effects of different vaccines developed throughout the world and their short and long-term effects, particularly COVID19 vaccines. Most notably, post-vaccination demyelinating diseases such as acute disseminated encephalomyelitis, transverse myelitis, and multiple sclerosis relapses have been reported. We present a case of a 32-year-old male who presented with a 2 weeks history of acute confusional state and imbalance 1 week after receiving the second dose of COVID19 vaccination. MRI findings showed typical distribution of neuromyelitis optica spectrum disorder and the patient was positive for AQP4 IgG. The pathogenesis behind developing neuromyelitis optica and vaccines is still unknown. Few case reports have been reported of post-vaccination neuromyelitis optica spectrum disorder but to our knowledge, this would be the first case published of neuromyelitis optica following exposure to COVID19 vaccine.

Citing Articles

Central nervous system manifestations following vaccination against COVID-19.

Khatami S, Revheim M, Hoilund-Carlsen P, Alavi A, Ghorbani Shirkouhi S, Andalib S Brain Behav Immun Health. 2024; 38():100788.

PMID: 38818372 PMC: 11137405. DOI: 10.1016/j.bbih.2024.100788.


Clinical Research into Central Nervous System Inflammatory Demyelinating Diseases Related to COVID-19 Vaccines.

Cheng M, Ho H, Hsu J, Wang Y, Chen L, Lim S Diseases. 2024; 12(3).

PMID: 38534984 PMC: 10969393. DOI: 10.3390/diseases12030060.


Treatment and Rehabilitation of a Patient with Neuromyelitis Optica Spectrum Disorder-Induced Complete Spinal Cord Injury Following COVID-19 Vaccination: A Case Report.

Han J, Ryu S, Lim Y, Kim A, Jung T J Clin Med. 2024; 13(4).

PMID: 38398485 PMC: 10888719. DOI: 10.3390/jcm13041175.


COVID-19 and the risk of neuromyelitis optica spectrum disorder: a Mendelian randomization study.

Sun D, Du Q, Wang R, Shi Z, Chen H, Zhou H Front Immunol. 2023; 14:1207514.

PMID: 37575255 PMC: 10414539. DOI: 10.3389/fimmu.2023.1207514.


The Occurrence of Acute Disseminated Encephalomyelitis in SARS-CoV-2 Infection/Vaccination: Our Experience and a Systematic Review of the Literature.

Stoian A, Bajko Z, Stoian M, Cioflinc R, Niculescu R, Arbanasi E Vaccines (Basel). 2023; 11(7).

PMID: 37515041 PMC: 10385010. DOI: 10.3390/vaccines11071225.


References
1.
Kaur R, Dutta S, Bhardwaj P, Charan J, Dhingra S, Mitra P . Adverse Events Reported From  COVID-19 Vaccine Trials: A Systematic Review. Indian J Clin Biochem. 2021; 36(4):427-439. PMC: 7997788. DOI: 10.1007/s12291-021-00968-z. View

2.
Haidere M, Ratan Z, Nowroz S, Zaman S, Jung Y, Hosseinzadeh H . COVID-19 Vaccine: Critical Questions with Complicated Answers. Biomol Ther (Seoul). 2020; 29(1):1-10. PMC: 7771841. DOI: 10.4062/biomolther.2020.178. View

3.
Karussis D, Petrou P . The spectrum of post-vaccination inflammatory CNS demyelinating syndromes. Autoimmun Rev. 2014; 13(3):215-24. DOI: 10.1016/j.autrev.2013.10.003. View

4.
Dutra B, da Rocha A, Nunes R, Maia Junior A . Neuromyelitis Optica Spectrum Disorders: Spectrum of MR Imaging Findings and Their Differential Diagnosis. Radiographics. 2018; 38(1):169-193. DOI: 10.1148/rg.2018170141. View

5.
Flanagan E, Weinshenker B . Neuromyelitis optica spectrum disorders. Curr Neurol Neurosci Rep. 2014; 14(9):483. DOI: 10.1007/s11910-014-0483-3. View